<DOC>
	<DOC>NCT00733135</DOC>
	<brief_summary>This is a multi-center, non-randomized, single arm study of the SilverHawk™ /TurboHawk™ plaque excision systems when used in conjunction with SpiderFX™ embolic protection device in treatment of moderate to severely calcified peripheral arterial disease in the superficial femoral and/or popliteal arteries.</brief_summary>
	<brief_title>Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++)</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Provides written informed consent Willing to comply with followup evaluations at specified times Has leg pain due to peripheral arterial disease Disease located within the femoropopliteal artery Moderate to severe calcification Previously implanted stent(s) or stent graft(s) in target leg Life expectancy less than 12 months Has any planned surgical or endovascular intervention of target vessel 30 days before or after index procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>peripheral vascular disease</keyword>
	<keyword>atherectomy</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>calcified lesions</keyword>
</DOC>